Inogen Announces Participation in the KeyBanc Life Sciences & MedTech Investor Forum

Rhea-AI Summary

Inogen, Inc. (NASDAQ: INGN) announced participation in the KeyBanc Life Sciences & MedTech Investor Forum on March 23, 2022, at 4:30 p.m. ET. The company's President and CEO, Nabil Shabshab, and CFO, Kristin Caltrider, will present at the event. A webcast will be available on the Inogen Investor Relations website, with a replay accessible for 90 days post-presentation. Inogen specializes in developing and marketing portable oxygen concentrators for chronic respiratory conditions, aiming to enhance homecare solutions for patients.

Positive

• Participation in a reputable investor forum could enhance visibility among investors.
• Webcast availability supports transparent communication with stakeholders.

Negative

• None.

GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the KeyBanc Life Sciences & MedTech Investor Forum.

Inogen’s President and CEO, Nabil Shabshab, and CFO, Kristin Caltrider, are scheduled to present on Wednesday, March 23^rd, 2022 at 4:30 p.m. ET. Interested parties can access the webcast from the News / Events section of the Investor Relations page on the Inogen website at www.inogen.com. A webcast replay will be available approximately one hour after the conclusion of the live presentation and will remain available for 90 days.

Inogen has used, and intends to continue to use, its Investor Relations website, http://investor.inogen.com/, as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. For more information, visit http://investor.inogen.com/.

About Inogen

Inogen is a medical technology company offering innovative respiratory products for use in the homecare setting. Inogen primarily develops, manufactures, and markets innovative portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.

For more information, please visit www.inogen.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220310005369/en/

Investor Relations and Media Contacts

Bryan Locke, Mike DeGraff, Gabriella Coffey

ir@inogen.net

Source: Inogen, Inc.

FAQ

When will Inogen present at the KeyBanc Life Sciences & MedTech Investor Forum?

Inogen will present on March 23, 2022, at 4:30 p.m. ET.

Who will be presenting for Inogen at the conference?

President and CEO Nabil Shabshab and CFO Kristin Caltrider will present.

Where can I access Inogen's presentation during the investor forum?

The presentation can be accessed via the News / Events section on Inogen's Investor Relations website.

What is Inogen, Inc. known for?

Inogen is known for developing and marketing innovative portable oxygen concentrators for patients with chronic respiratory conditions.